| What is RSS feed? | About Us |
Source: www.reuters.com --- 29 days ago
CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical data. ... Source: www.marketwatch.com --- 29 days ago
BOSTON (MarketWatch) -- Shares of Allergan Inc. shot up more than 10% on Thursday following the release of favorable test data for its anti-wrinkle product Botox in the treatment of chronic migraine headaches. ... Source: www.forbes.com --- 29 days ago
The drugmaker's shares jumped after it reported that its anti-wrinkle injection may also be a headache reliever. ... Source: www.forbes.com --- 29 days ago
The drugmaker's shares soared on the news that its anti-wrinkle injection may also relieve headaches. ... Source: www.businessweek.com --- 29 days ago
... Source: www.marketwatch.com --- 29 days ago
Drug stocks slip in early action; Allergan leaps on positive study showing its product Botox is beneficial in the treatment of migraine headaches. ... Source: www.chron.com --- 29 days ago
IRVINE, Calif. — Shares of Allergan Inc. jumped Thursday after the drugmaker reported that its antiwrinkle injection Botox may help relieve migraine headaches. The company said it will ask the Food and Drug Administration next year to approve Botox for chronic migraine, based on preliminary analysis of two new studies. ... Source: losangeles.bizjournals.com --- 29 days ago
Shares of Allergan Inc. are up nearly 11 percent in midday trading after the company released positive findings about a new use for the company's signature product, Botox. (AGN) ... Source: www.businesswire.com --- 7 days ago
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jeff Edwards, Executive Vice ... Source: www.moreover.com --- 27 days ago
Datamonitor Sep 13 2008 3:25AM GMT ... Source: industry.bnet.com --- 14 days ago
Medicis stock tumbled roughly 16 percent yesterday after it announced that it would restate six years of its numbers due to an accounting error. But the magnitude of the fall seems to have drawn attention not to the vanity pharma company’s inability to count beans, but the weakness of its key Solodyn acne franchise, and the [...] ... Source: www.moreover.com --- 29 days ago
BusinessWeek Sep 11 2008 7:35PM GMT ... Source: www.drugs.com --- 27 days ago
-- Phase III Studies Show Statistically Significant Decrease in Number of Headache Days -- IRVINE, Calif., Sep 11, 2008 (BUSINESS WIRE) -- Allergan, Inc. (NYSE: AGN) today announced that it has completed a top-line analysis of its two Phase III... ... Source: www.moreover.com --- 16 days ago
Earthtimes.org Sep 24 2008 10:38AM GMT ... Source: www.postchronicle.com --- 28 days ago
Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines,...... ... Find more results for Allergan on RSSMicro.com |
Copyright © 2008 RSSMicro.com